-
1
-
-
84877833484
-
-
In the Pipeline (blog Sept 26, 2011). "Predicting toxic drug effects in humans-now, that's something we could use more of. Plenty of otherwise viable clinical candidates go down because of unexpected toxicities, sometimes in terribly expensive and time-wasting ways. But predictive toxicology has proven extremely hard to realize, and it's not hard to see why: there must be a million things that can go wrong, and how many of them have we even heard of? And of the ones we have some clue about, how many of them do we have tests for? See also the 2011 Thomson Reuters report The Changing Role of Chemistry in Drug Discovery
-
D. Lowe. In the Pipeline (blog Sept 26, 2011). "Predicting toxic drug effects in humans-now, that's something we could use more of. Plenty of otherwise viable clinical candidates go down because of unexpected toxicities, sometimes in terribly expensive and time-wasting ways. But predictive toxicology has proven extremely hard to realize, and it's not hard to see why: there must be a million things that can go wrong, and how many of them have we even heard of? And of the ones we have some clue about, how many of them do we have tests for? See also the 2011 Thomson Reuters report The Changing Role of Chemistry in Drug Discovery.
-
-
-
Lowe, D.1
-
2
-
-
60749088028
-
In vitro screening techniques for reactive metabolites for minimizing bioactivation potential in drug discovery
-
Prakash, C.; Sharma, R.; Gleave, M.; Nedderman, A. In vitro screening techniques for reactive metabolites for minimizing bioactivation potential in drug discovery. Curr. Drug Metab. 2008, 9, 952-964.
-
(2008)
Curr. Drug Metab
, vol.9
, pp. 952-964
-
-
Prakash, C.1
Sharma, R.2
Gleave, M.3
Nedderman, A.4
-
3
-
-
79953314978
-
Managing the challenge of chemically reactive metabolites in drug development
-
Park BK.; Boobis A, Clarke S.; Goldring CE, Jones D.; Kenna JG, Lambert C.; Laverty HG, Naisbitt DJ.; Nelson S, Nicoll-Griffith DA.; Obach RS, Routledge P.; Smith DA, Tweedie DJ.; Vermeulen N, Williams DP.; Wilson ID.; Baillie TA. Managing the challenge of chemically reactive metabolites in drug development. Nat. Rev. Drug Discov. 2011, 10, 292-306.
-
(2011)
Nat. Rev. Drug Discov
, vol.10
, pp. 292-306
-
-
Park, B.K.1
Boobis, A.2
Clarke, S.3
Goldring, C.E.4
Jones, D.5
Kenna, J.G.6
Lambert, C.7
Laverty, H.G.8
Naisbitt, D.J.9
Nelson, S.10
Nicoll-Griffith, D.A.11
Obach, R.S.12
Routledge, P.13
Smith, D.A.14
Tweedie, D.J.15
Vermeulen, N.16
Williams, D.P.17
Wilson, I.D.18
Baillie, T.A.19
-
4
-
-
79951990726
-
Bioactivation of drugs: Risk and drug design
-
Walsh, J. S.; Miwa, G. T. Bioactivation of drugs: risk and drug design. Annu. Rev. Pharmacol. Toxicol. 2011, 51, 145-167.
-
(2011)
Annu. Rev. Pharmacol. Toxicol
, vol.51
, pp. 145-167
-
-
Walsh, J.S.1
Miwa, G.T.2
-
5
-
-
74949091029
-
Oxidative stress drives disulfide bond formation between basic helix-loop-helix transcription factors
-
Danciu, T. E.; Whitman, M. Oxidative stress drives disulfide bond formation between basic helix-loop-helix transcription factors. J. Cell. Biochem. 2010, 109, 417-424.
-
(2010)
J. Cell. Biochem
, vol.109
, pp. 417-424
-
-
Danciu, T.E.1
Whitman, M.2
-
6
-
-
77951435259
-
Metabolic bioactivation and drug-related adverse effects: Current status and future directions from a pharmaceutical research perspective
-
Tang, W.; Lu, A. Y. H. Metabolic bioactivation and drug-related adverse effects: current status and future directions from a pharmaceutical research perspective. Drug Metab. Rev. 2010, 42, 225-249.
-
(2010)
Drug Metab. Rev
, vol.42
, pp. 225-249
-
-
Tang, W.1
Lu, A.Y.H.2
-
7
-
-
79551679354
-
Strategies and chemical design approaches to reduce the potential for formation of reactive metabolic species
-
Argikar, U. A.; Mangold, J. B.; Harriman, S. P. Strategies and chemical design approaches to reduce the potential for formation of reactive metabolic species. Curr. Top. Med. Chem. 2011, 11, 419-449.
-
(2011)
Curr. Top. Med. Chem
, vol.11
, pp. 419-449
-
-
Argikar, U.A.1
Mangold, J.B.2
Harriman, S.P.3
-
8
-
-
79958047253
-
Risk assessment and mitigation strategies for reactive metabolites in drug discovery and development
-
Thompson, R. A.; Isin, E. M.; Li, Y.; Weaver, R.; Weidolf, L.; Wilson, I.; Claesson, A.; Page, K.; Dolgos, H.; Kenna, J. G. Risk assessment and mitigation strategies for reactive metabolites in drug discovery and development. Chem. Biol. Interact. 2011, 192, 65-71.
-
(2011)
Chem. Biol. Interact
, vol.192
, pp. 65-71
-
-
Thompson, R.A.1
Isin, E.M.2
Li, Y.3
Weaver, R.4
Weidolf, L.5
Wilson, I.6
Claesson, A.7
Page, K.8
Dolgos, H.9
Kenna, J.G.10
-
9
-
-
80053004364
-
Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: A perspective based on the critical examination of trends in the top 200 drugs marketed in the United States
-
Stepan, A. F.; Walker, D. P.; Bauman, J.; Price, D. A.; Baillie, T. A.; Kalgutkar, A. S.; Aleo, M. D. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States. Chem. Res. Toxicol. 2011, 24, 1345-1410.
-
(2011)
Chem. Res. Toxicol
, vol.24
, pp. 1345-1410
-
-
Stepan, A.F.1
Walker, D.P.2
Bauman, J.3
Price, D.A.4
Baillie, T.A.5
Kalgutkar, A.S.6
Aleo, M.D.7
-
10
-
-
70350273017
-
Structural alerts, reactive metabolites, and protein covalent binding: How reliable are these attributes as predictors of drug toxicity?
-
Kalgutkar, A.; Didiuk, M. structural alerts, reactive metabolites, and protein covalent binding: how reliable are these attributes as predictors of drug toxicity? Chem. Biodivers. 2009, 6, 2115-2137.
-
(2009)
Chem. Biodivers
, vol.6
, pp. 2115-2137
-
-
Kalgutkar, A.1
Didiuk, M.2
-
11
-
-
19944399431
-
Comprehensive listing of bioactivation pathways of organic functional groups
-
Kalgutkar, A. S.; Gardner, I.; Obach, R. S.; Shaffer, C. L.; Callegari, E.; Henne, K. R.; Mutlib, A. E.; Dalvie, D. K.; Lee, J. S.; Nakai, Y.; O'Donnell, J. P.; Boer, J.; Harriman, S. P. A comprehensive listing of bioactivation pathways of organic functional groups. Curr. Drug Metab. 2005, 6, 161-225.
-
(2005)
Curr. Drug Metab
, vol.6
, pp. 161-225
-
-
Kalgutkar, A.S.1
Gardner, I.2
Obach, R.S.3
Shaffer, C.L.4
Callegari, E.5
Henne, K.R.6
Mutlib, A.E.7
Dalvie, D.K.8
Lee, J.S.9
Nakai, Y.10
O'Donnell, J.P.11
Boer, J.12
Harriman, S.P.13
-
12
-
-
0031719374
-
Role of drug disposition in drug hypersensitivity: A chemical, molecular, and clinical perspective
-
Park, B. K.; Pirmohamed, M.; Kitteringham, N. R. Role of drug disposition in drug hypersensitivity: a chemical, molecular, and clinical perspective. Chem. Res. Toxicol. 1998, 11, 969-988.
-
(1998)
Chem. Res. Toxicol
, vol.11
, pp. 969-988
-
-
Park, B.K.1
Pirmohamed, M.2
Kitteringham, N.R.3
-
13
-
-
0029555342
-
Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to the cells
-
Liu, Z. C.; Uetrecht, J. P. Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to the cells. J. Pharmacol. Exp. Ther. 1995, 275, 1476-1483.
-
(1995)
J. Pharmacol. Exp. Ther
, vol.275
, pp. 1476-1483
-
-
Liu, Z.C.1
Uetrecht, J.P.2
-
14
-
-
33645220583
-
Drug-induced liver injury: Summary of a single topic clinical research conference
-
Watkins, P. B.; Seeff, L. B. Drug-induced liver injury: summary of a single topic clinical research conference. Hepatology 2006, 43, 618-631.
-
(2006)
Hepatology
, vol.43
, pp. 618-631
-
-
Watkins, P.B.1
Seeff, L.B.2
-
15
-
-
66149104042
-
In vitro screening of 50 highly prescribed drugs for thiol adduct formation--comparison of potential for drug-induced toxicity and extent of adduct formation
-
Gan, J.; Ruan, Q.; He, B.; Zhu, M.; Shyu, W. C.; Humphreys, W. G. In vitro screening of 50 highly prescribed drugs for thiol adduct formation--comparison of potential for drug-induced toxicity and extent of adduct formation. Chem. Res. Toxicol. 2009, 22, 690-698.
-
(2009)
Chem. Res. Toxicol
, vol.22
, pp. 690-698
-
-
Gan, J.1
Ruan, Q.2
He, B.3
Zhu, M.4
Shyu, W.C.5
Humphreys, W.G.6
-
16
-
-
53549100467
-
Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose
-
Obach, R. S.; Kalgutkar, A. S.; Soglia, J. R.; Zhao, S. X. Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose. Chem. Res. Toxicol. 2008, 21, 1814-1822.
-
(2008)
Chem. Res. Toxicol
, vol.21
, pp. 1814-1822
-
-
Obach, R.S.1
Kalgutkar, A.S.2
Soglia, J.R.3
Zhao, S.X.4
-
17
-
-
70349103856
-
A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding
-
Nakayama, S.; Atsumi, R.; Takakusa, H.; Kobayashi, Y.; Kurihara, A.; Nagai, Y.; Nakai, D.; Okazaki, O. A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding. Drug Metab. Disp. 2009, 37, 1970-1977.
-
(2009)
Drug Metab. Disp
, vol.37
, pp. 1970-1977
-
-
Nakayama, S.1
Atsumi, R.2
Takakusa, H.3
Kobayashi, Y.4
Kurihara, A.5
Nagai, Y.6
Nakai, D.7
Okazaki, O.8
-
18
-
-
84855833516
-
Strategies to mitigate the bioactivation of 2-anilino-7-aryl-pyrrolo[2,1-f][1,2,4]triazines: Identification of orally bioavailable, efficacious ALK inhibitors
-
Mesaros, E. F., et al. Strategies to mitigate the bioactivation of 2-anilino-7-aryl-pyrrolo[2,1-f][1,2,4]triazines: identification of orally bioavailable, efficacious ALK inhibitors. J. Med. Chem. 2012, 55, 115-125.
-
(2012)
J. Med. Chem
, vol.55
, pp. 115-125
-
-
Mesaros, E.F.1
-
19
-
-
80052974259
-
Improving drug candidates by design: A focus on physicochemical properties as a means of improving compound disposition and safety
-
Meanwell, N. A. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety. Chem. Res. Toxicol. 2011, 24, 1420-1456.
-
(2011)
Chem. Res. Toxicol
, vol.24
, pp. 1420-1456
-
-
Meanwell, N.A.1
-
20
-
-
35748934487
-
The influence of drug-like concepts on decision-making in medicinal chemistry
-
Leeson, P. D.; Springthorpe, B. The influence of drug-like concepts on decision-making in medicinal chemistry. Nat. Rev. Drug Discov. 2007, 6, 881-890.
-
(2007)
Nat. Rev. Drug Discov
, vol.6
, pp. 881-890
-
-
Leeson, P.D.1
Springthorpe, B.2
-
21
-
-
72149091750
-
Physicochemical property profiles of marketed drugs, clinical candidates and bioactive compounds
-
Tyrchan, C.; Blomberg, N.; Engkvist, O.; Kogej, T.; Muresan, S. Physicochemical property profiles of marketed drugs, clinical candidates and bioactive compounds. Bioorg. Med. Chem. Lett. 2009, 19, 6943.
-
(2009)
Bioorg. Med. Chem. Lett
, vol.19
, pp. 6943
-
-
Tyrchan, C.1
Blomberg, N.2
Engkvist, O.3
Kogej, T.4
Muresan, S.5
-
22
-
-
80053471789
-
The influence of the 'organizational factor' on compound quality in drug discovery
-
Leeson, P. D.; St-Gallay, S. The influence of the 'organizational factor' on compound quality in drug discovery. Nat. Rev. Drug Disc. 2011, 10, 749-765.
-
(2011)
Nat. Rev. Drug Disc
, vol.10
, pp. 749-765
-
-
Leeson, P.D.1
St-Gallay, S.2
-
23
-
-
79959434611
-
Comparative evaluation of in silico systems for ames test mutagenicity prediction: Scope and limitations
-
Hillebrecht, A.; Muster, W.; Brigo, A.; Kansy, M.; Weiser, T.; Singer, T. Comparative evaluation of in silico systems for ames test mutagenicity prediction: scope and limitations. Chem. Res. Toxicol. 2011, 24, 843-854.
-
(2011)
Chem. Res. Toxicol
, vol.24
, pp. 843-854
-
-
Hillebrecht, A.1
Muster, W.2
Brigo, A.3
Kansy, M.4
Weiser, T.5
Singer, T.6
-
24
-
-
80051962255
-
Integrated decision support for assessing chemical liabilities
-
Spjuth, O.; Eklund, M.; Ahlberg Helgee, E.; Boyer, S.; Carlsson, L. Integrated decision support for assessing chemical liabilities. J. Chem. Inf. Model. 2011, 51, 1840-1847.
-
(2011)
J. Chem. Inf. Model
, vol.51
, pp. 1840-1847
-
-
Spjuth, O.1
Eklund, M.2
Ahlberg Helgee, E.3
Boyer, S.4
Carlsson, L.5
-
25
-
-
62249155473
-
Can in vitro metabolism-dependent covalent binding data distinguish hepatotoxic from nonhepatotoxicdrugs? An analysis using human hepatocytes and liver S-9 fraction
-
Bauman, J. N.; Kelly, J. M.; Tripathy, S.; Zhao, S. X.; Lam, W. W.; Kalgutkar, A. S.; Obach, R. S. Can in vitro metabolism-dependent covalent binding data distinguish hepatotoxic from nonhepatotoxicdrugs? An analysis using human hepatocytes and liver S-9 fraction. Chem. Res. Toxicol. 2009, 22, 332-340.
-
(2009)
Chem. Res. Toxicol
, vol.22
, pp. 332-340
-
-
Bauman, J.N.1
Kelly, J.M.2
Tripathy, S.3
Zhao, S.X.4
Lam, W.W.5
Kalgutkar, A.S.6
Obach, R.S.7
-
26
-
-
71049126548
-
Escape from Flatland: Increasing saturation as an approach to improving clinical success
-
Lovering, F.; Bikker, J.; Humblet, C. Escape from Flatland: increasing saturation as an approach to improving clinical success. J. Med. Chem. 2009, 52, 6752-6756.
-
(2009)
J. Med. Chem
, vol.52
, pp. 6752-6756
-
-
Lovering, F.1
Bikker, J.2
Humblet, C.3
-
27
-
-
70350409235
-
The impact of aromatic ring count on compound developability-are too many aromatic rings a liability in drug design?
-
Ritchie, T. J.; Macdonald, S. J. F. The impact of aromatic ring count on compound developability-are too many aromatic rings a liability in drug design? Drug Discov. Today 2009, 14, 1011-1020.
-
(2009)
Drug Discov. Today
, vol.14
, pp. 1011-1020
-
-
Ritchie, T.J.1
MacDonald, S.J.F.2
-
28
-
-
80052601462
-
Strategies to improve in vivo toxicology outcomes for basic candidate drug molecules
-
Luker, T.; Alcaraz, L.; Chohan, K. K.; Blomberg, N.; Brown, D. S.; Butlin, R. J.; Elebring, T.; Griffin, A. M.; Guile, S.; St-Gallay, S.; Swahn, B. M.; Swallow, S.; Waring, M. J.; Wenlock, M. C.; Leeson, P. D. Strategies to improve in vivo toxicology outcomes for basic candidate drug molecules. Bioorg. Med. Chem. Lett. 2011, 21, 5673-5679.
-
(2011)
Bioorg. Med. Chem. Lett
, vol.21
, pp. 5673-5679
-
-
Luker, T.1
Alcaraz, L.2
Chohan, K.K.3
Blomberg, N.4
Brown, D.S.5
Butlin, R.J.6
Elebring, T.7
Griffin, A.M.8
Guile, S.9
St-Gallay, S.10
Swahn, B.M.11
Swallow, S.12
Waring, M.J.13
Wenlock, M.C.14
Leeson, P.D.15
-
29
-
-
79957698619
-
The medicinal chemists' toolbox: An analysis of reactions used in the pursuit of drug candidates
-
Roughley, S. D.; Jordan, A. M. The medicinal chemists' toolbox: an analysis of reactions used in the pursuit of drug candidates. J. Med. Chem. 2011, 54, 3451-3479.
-
(2011)
J. Med. Chem
, vol.54
, pp. 3451-3479
-
-
Roughley, S.D.1
Jordan, A.M.2
-
30
-
-
84861646776
-
Reactions and enzymes in the metabolism of drugs and other xenobiotics
-
Testa, B.; Pedretti, A.; Vistoli, G. Reactions and enzymes in the metabolism of drugs and other xenobiotics. Drug Discov. Today 2012, 17, 549-560.
-
(2012)
Drug Discov. Today
, vol.17
, pp. 549-560
-
-
Testa, B.1
Pedretti, A.2
Vistoli, G.3
-
31
-
-
19944412145
-
Metabolism, pharmacokinetics, and protein covalent binding of radiolabeled maxipost [BMS-204352] in humans
-
Zhang, D.; Krishna, R.; Wang, L.; Zeng, J.; Mitroka, J.; Dai, R.; Narasimhan, N.; Reeves, R. A.; Srinivas, N. R.; Klunk, L. J. Metabolism, pharmacokinetics, and protein covalent binding of radiolabeled maxipost [BMS-204352] in humans. Drug Metab. Disp. 2005, 33, 83-93.
-
(2005)
Drug Metab. Disp
, vol.33
, pp. 83-93
-
-
Zhang, D.1
Krishna, R.2
Wang, L.3
Zeng, J.4
Mitroka, J.5
Dai, R.6
Narasimhan, N.7
Reeves, R.A.8
Srinivas, N.R.9
Klunk, L.J.10
-
32
-
-
44149108220
-
Comparison of the bioactivation potential of the antidepressant and hepatotoxin nefazodone with aripiprazole, a structural analog and marketed drug
-
Bauman, J. N.; Frederick, K. S.; Sawant, A.; Walsky, R. L.; Cox, L. M.; Obach, R. S.; Kalgutkar, A. S. Comparison of the bioactivation potential of the antidepressant and hepatotoxin nefazodone with aripiprazole, a structural analog and marketed drug. Drug Metab. Dispos. 2008, 36, 1016-1029.
-
(2008)
Drug Metab. Dispos
, vol.36
, pp. 1016-1029
-
-
Bauman, J.N.1
Frederick, K.S.2
Sawant, A.3
Walsky, R.L.4
Cox, L.M.5
Obach, R.S.6
Kalgutkar, A.S.7
-
33
-
-
20844454730
-
Bioactivation of the nontricyclic antidepressant nefazodone to a reactive quinone-imine species in human liver microsomes and recombinant cytochrome P450 3A4
-
Kalgutkar, A. S.; Vaz, A. D. N.; Lame, M. E.; Henne, K. R.; Soglia, J.; Zhao, S. X.; Abramov, Y. A.; Lombardo, F.; Collin, C.; Hendsch, Z. S.; Hop, C. E. C. A. Bioactivation of the nontricyclic antidepressant nefazodone to a reactive quinone-imine species in human liver microsomes and recombinant cytochrome P450 3A4. Drug Metab. Dispos. 2005, 33, 243-253.
-
(2005)
Drug Metab. Dispos
, vol.33
, pp. 243-253
-
-
Kalgutkar, A.S.1
Vaz, A.D.N.2
Lame, M.E.3
Henne, K.R.4
Soglia, J.5
Zhao, S.X.6
Abramov, Y.A.7
Lombardo, F.8
Collin, C.9
Hendsch, Z.S.10
Hop, C.E.C.A.11
-
34
-
-
61849090255
-
Bioactivation of lumiracoxib by peroxidases and human liver microsomes: Identification of multiple quinone imine intermediates and GSH Adducts
-
Kang, P.; Dalvie, D.; Smith, E.; Renner, M. Bioactivation of lumiracoxib by peroxidases and human liver microsomes: identification of multiple quinone imine intermediates and GSH Adducts. Chem. Res. Toxicol. 2009, 22, 106-117.
-
(2009)
Chem. Res. Toxicol
, vol.22
, pp. 106-117
-
-
Kang, P.1
Dalvie, D.2
Smith, E.3
Renner, M.4
-
35
-
-
70350246251
-
Bioactivation of the Epidermal growth factor receptor inhibitor gefitinib: Implications for pulmonary and hepatic toxicities
-
Li, X.; Kamenecka, T. M.; Cameron, M. D. Bioactivation of the Epidermal growth factor receptor inhibitor gefitinib: implications for pulmonary and hepatic toxicities. Chem. Res. Toxicol. 2009, 22, 1736-1742.
-
(2009)
Chem. Res. Toxicol
, vol.22
, pp. 1736-1742
-
-
Li, X.1
Kamenecka, T.M.2
Cameron, M.D.3
-
36
-
-
0036127307
-
Biotransformation reactions of five-membered aromatic heterocyclic rings
-
Dalvie, D. K.; Kalgutkar, A. S.; Khojasteh-Bakht, S.; Obach, R. S.; O'Donnell, J. P. biotransformation reactions of five-membered aromatic heterocyclic rings. Chem. Res. Toxicol. 2002, 15, 269-299.
-
(2002)
Chem. Res. Toxicol
, vol.15
, pp. 269-299
-
-
Dalvie, D.K.1
Kalgutkar, A.S.2
Khojasteh-Bakht, S.3
Obach, R.S.4
O'Donnell, J.P.5
-
37
-
-
0030895445
-
Production and characterization of specific antibodies: Utilization to predict organ-and species-selective pneumotoxicity of 3-methylindole
-
Kaster, J. K.; Yost, G. S. Production and characterization of specific antibodies: utilization to predict organ-and species-selective pneumotoxicity of 3-methylindole. Toxicol. Appl. Pharmacol. 1997, 143, 324-337.
-
(1997)
Toxicol. Appl Pharmacol
, vol.143
, pp. 324-337
-
-
Kaster, J.K.1
Yost, G.S.2
-
38
-
-
0026668007
-
Identification of a cysteinyl adduct of oxidized 3-methylindole from goat lung and human liver microsomal proteins
-
Ruangyuttikarn, W.; Skiles, G. L.; Yost, G. S. Identification of a cysteinyl adduct of oxidized 3-methylindole from goat lung and human liver microsomal proteins. Chem. Res. Toxicol. 1992, 5, 713-719.
-
(1992)
Chem. Res. Toxicol
, vol.5
, pp. 713-719
-
-
Ruangyuttikarn, W.1
Skiles, G.L.2
Yost, G.S.3
-
39
-
-
53549107196
-
In vitro metabolism and covalent binding of enol-carboxamide derivatives and anti-inflammatory agents sudoxicam and meloxicam: Insights into the hepatotoxicity of sudoxicam
-
Obach, R. S.; Kalgutkar, A. S.; Ryder, T. F.; Walker, G. S. In vitro metabolism and covalent binding of enol-carboxamide derivatives and anti-inflammatory agents sudoxicam and meloxicam: insights into the hepatotoxicity of sudoxicam. Chem. Res. Toxicol. 2008, 21, 1890-1899.
-
(2008)
Chem. Res. Toxicol
, vol.21
, pp. 1890-1899
-
-
Obach, R.S.1
Kalgutkar, A.S.2
Ryder, T.F.3
Walker, G.S.4
-
40
-
-
80053521566
-
Explanation for main features of structure-genotoxicity relationships of aromatic amines by theoretical studies of their activation pathways in CYP1A2
-
Shamovsky, I.; Ripa, L.; Borjesson, L.; Mee, C.; Norden, B.; Hansen, P.; Hasselgren, C.; O'Donovan, M.; Sjo, P. explanation for main features of structure-genotoxicity relationships of aromatic amines by theoretical studies of their activation pathways in CYP1A2. J. Am. Chem. Soc. 2011, 133, 16168-16185.
-
(2011)
J. Am. Chem. Soc
, vol.133
, pp. 16168-16185
-
-
Shamovsky, I.1
Ripa, L.2
Borjesson, L.3
Mee, C.4
Norden, B.5
Hansen, P.6
Hasselgren, C.7
O'Donovan, M.8
Sjo, P.9
-
41
-
-
84862667032
-
An investigation into pharmaceutically relevant mutagenicity data and the influence on Ames Predictive Potential
-
McCarren, P.; Springer, C.; Whitehead, L. An investigation into pharmaceutically relevant mutagenicity data and the influence on Ames Predictive Potential. J. Cheminf. 2011, 3, 51.
-
(2011)
J. Cheminf
, vol.3
, pp. 51
-
-
McCarren, P.1
Springer, C.2
Whitehead, L.3
-
42
-
-
0035996573
-
On the diversity of oxidative bioactivation reactions on nitrogen-containing xenobiotics
-
Kalgutkar, A. S.; Dalvie, D. K.; O'Donnell, J. P.; Taylor, T. J.; Sahakian, D. C. On the diversity of oxidative bioactivation reactions on nitrogen-containing xenobiotics. Curr. Drug Metab. 2002, 3, 379-424.
-
(2002)
Curr. Drug Metab
, vol.3
, pp. 379-424
-
-
Kalgutkar, A.S.1
Dalvie, D.K.2
O'Donnell, J.P.3
Taylor, T.J.4
Sahakian, D.C.5
-
43
-
-
44349171209
-
Metabolic activation of carboxylic acids
-
Skonberg, C.; Olsen, J.; Madsen, K. G.; Hansen, S. H.; Grillo, M. P. Metabolic activation of carboxylic acids. Expert Opin. Drug Metab. Toxicol. 2008, 4, 425-438.
-
(2008)
Expert Opin. Drug Metab. Toxicol
, vol.4
, pp. 425-438
-
-
Skonberg, C.1
Olsen, J.2
Madsen, K.G.3
Hansen, S.H.4
Grillo, M.P.5
-
44
-
-
0035703703
-
Molecular mechanisms of adverse drug reactions
-
Nelson, S. D. Molecular mechanisms of adverse drug reactions. Curr. Ther. Res. 2001, 62, 885-899.
-
(2001)
Curr. Ther. Res
, vol.62
, pp. 885-899
-
-
Nelson, S.D.1
-
45
-
-
77954048869
-
Use of historic metabolic biotransformation data as a means of anticipating metabolic sites using MetaPrint2D and Bioclipse
-
Carlsson, L.; Spjuth, O.; Adams, S.; Glen, R.; Boyer, S. Use of historic metabolic biotransformation data as a means of anticipating metabolic sites using MetaPrint2D and Bioclipse. BMC Bioinformatics 2010, 11, 362.
-
(2010)
BMC Bioinformatics
, vol.11
, pp. 362
-
-
Carlsson, L.1
Spjuth, O.2
Adams, S.3
Glen, R.4
Boyer, S.5
-
46
-
-
77953932263
-
SMARTCyp: A 2D Method for prediction of cytochrome p450-mediated drug metabolism
-
Rydberg, P.; Gloriam, D. E.; Zaretzki, J.; Breneman, C.; Olsen, L. SMARTCyp: A 2D Method for prediction of cytochrome p450-mediated drug metabolism. ACS Med. Chem. Lett. 2010, 1, 96-100.
-
(2010)
ACS Med. Chem. Lett
, vol.1
, pp. 96-100
-
-
Rydberg, P.1
Gloriam, D.E.2
Zaretzki, J.3
Breneman, C.4
Olsen, L.5
-
47
-
-
80054767651
-
Evaluation of three state-of-the-art metabolite prediction software packages (meteor, metasite, and stardrop) through independent and synergistic use
-
T'jollyn, H.; Boussery, K.; Mortishire-Smith, R. J.; Coe, K.; De Boeck, B.; Van Bocxlaer, J. F.; Mannens, G. Evaluation of three state-of-the-art metabolite prediction software packages (meteor, metasite, and stardrop) through independent and synergistic use. Drug Metab. Disp. 2011, 39, 2066-2075.
-
(2011)
Drug Metab. Disp
, vol.39
, pp. 2066-2075
-
-
T'jollyn, H.1
Boussery, K.2
Mortishire-Smith, R.J.3
Coe, K.4
de Boeck, B.5
Van Bocxlaer, J.F.6
Mannens, G.7
-
48
-
-
80053928594
-
What do medicinal chemists actually make? a 50-year retrospective
-
Walters, W. P.; Green, J.; Weiss, J. R.; Murcko, M. A. What do medicinal chemists actually make? a 50-year retrospective. J. Med. Chem. 2011, 54, 6405-6416.
-
(2011)
J. Med. Chem
, vol.54
, pp. 6405-6416
-
-
Walters, W.P.1
Green, J.2
Weiss, J.R.3
Murcko, M.A.4
-
49
-
-
13844250566
-
Metabolic activation of a 1,3-disubstituted piperazine derivative: Evidence for a novel ring contraction to an imidazoline
-
Doss, G. A.; Miller, R. R.; Zhang, Z.; Teffera, Y.; Nargund, R. P.; Palucki, B.; Park, M. K.; Tang, Y. S.; Evans, D. C.; Baillie, T. A.; Stearns, R. A. Metabolic activation of a 1,3-disubstituted piperazine derivative: evidence for a novel ring contraction to an imidazoline. Chem. Res. Toxicol. 2005, 18, 271-276.
-
(2005)
Chem. Res. Toxicol
, vol.18
, pp. 271-276
-
-
Doss, G.A.1
Miller, R.R.2
Zhang, Z.3
Teffera, Y.4
Nargund, R.P.5
Palucki, B.6
Park, M.K.7
Tang, Y.S.8
Evans, D.C.9
Baillie, T.A.10
Stearns, R.A.11
|